The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Valganciclovir Results in Improved Oral Absorption of Ganciclovir in Liver Transplant Recipients
Open accessAbstract
The pharmacokinetics of an orally administered valine ester of ganciclovir (GCV), valganciclovir (VGC), were studied. These were compared to the pharmacokinetics of oral and intravenous GCV. Twenty-eight liver transplant recipients received, in an open-label random order with a 3- to 7-day washout, each of the following: 1 g of oral GCV three times a day; 450 mg of VGC per os (p.o.) once a day (q.d.); 900 mg of VGC p.o. q.d.; and 5 mg of intravenous (i.v.) GCV per kg of body weight q.d., given over 1 h. GCV and VGC concentrations were measured in blood over 24 h. One-sided equivalence testing was performed to test for noninferiority of 450 mg of VGC relative to oral GCV (two-sided 90% confidence interval [CI] > 80%) and nonsuperiority of 900 mg of VGC relative to i.v. GCV (two-sided 90% CI < 125%). The exposure of 450 mg of VGC (20.56 μg · h/ml) was found to be noninferior to that of oral GCV (20.15 μg · h/ml; 90% CI for relative bioavailability of 95 to 109%), and the exposure of 900 mg of VGC (42.69 μg · h/ml) was found to be nonsuperior to that of i.v. GCV (47.61 μg · h/ml; 90% CI = 83 to 97%). Oral VGC delivers systemic GCV exposure equivalent to that of standard oral GCV (at 450 mg) or i.v. GCV (at 900 mg of VGC). VGC has promise for effective CMV prophylaxis or treatment with once-daily oral dosing in transplant recipients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Potential Role of Human Cytomegalovirus and p53 Interaction in Coronary Restenosis
Speir, E., Modali, R., Huang, E.-S., Leon, M. B., Shawl, F., Finkel, T., & Epstein, S. E. (1994) · Science · doi:10.1126/science.8023160 · Cited by 753
Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal Transplantation
Lowance, D., Neumayer, H.-H., Legendre, C. M., Squifflet, J.-P., Kovarik, J., Brennan, P. J., Norman, D., Mendez, R., Keating, M. R., Coggon, G. L., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905133401903 · Cited by 712
Gane, E., Saliba, F., Valdecasas, G. J., O'Grady, J., Pescovitz, M. D., Lyman, S., & Robinson, C. A. (1997) · The Lancet · doi:10.1016/s0140-6736(97)05535-9 · Cited by 496
Self-citationSolez, K., Vincenti, F., & Filo, R. S. (1998) · Transplantation · doi:10.1097/00007890-199812270-00029 · Cited by 366
Valacyclovir: A Substrate for the Intestinal and Renal Peptide Transporters PEPT1 and PEPT2
Ganapathy, M. E., Huang, W. Y., Wang, H., Ganapathy, V., & Leibach, F. H. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8628 · Cited by 301
Valantine, H. A., Gao, S.-Z., Menon, S. G., Renlund, D. G., Hunt, S. A., Oyer, P., Stinson, E. B., Brown, B. W., Merigan, T. C., & Schroeder, J. S. (1999) · Circulation · doi:10.1161/01.cir.100.1.61 · Cited by 292
Winston, D. J., Wirin, D., Shaked, A., & Busuttil, R. W. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92110-9 · Cited by 261
CYTOMEGALOVIRUS PROPHYLAXIS IN SOLID ORGAN TRANSPLANT RECIPIENTS
Patel, R., Snydman, D. R., Rubin, R. H., Ho, M., Pescovitz, M., Martin, M., & Paya, C. V. (1996) · Transplantation · doi:10.1097/00007890-199605150-00001 · Cited by 193
Self-citationCytomegalovirus Infection Following Liver Transplantation: Review of the Literature
Kanj, S. S., Sharara, A. I., Clavien, P.-A., & Hamilton, J. D. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.3.537 · Cited by 159
Brown, F., Banken, L., Saywell, K. L., & Arum, I. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199937020-00005 · Cited by 158
Self-citationSinko, P. J., & Balimane, P. V. (1998) · Biopharmaceutics & Drug Disposition · Cited by 84
ORAL GANCICLOVIR DOSING IN TRANSPLANT RECIPIENTS AND DIALYSIS PATIENTS BASED ON RENAL FUNCTION1
Pescovitz, M. D., Pruett, T. L., Gonwa, T. A., Brook, B., McGory, R. W., Wicker, K., Griffy, K. G., Robinson, C. A., & Jung, D. T. (1998) · Transplantation · doi:10.1097/00007890-199810270-00023 · Cited by 44
Self-citationPaterson, D. L., Stapelfeldt, W. H., Wagener, M. M., Gayowski, T., Marino, I. R., & Singh, N. (1999) · Transplantation · doi:10.1097/00007890-199904270-00011 · Cited by 35
Oral ganciclovir in pediatric transplant recipients: a pharmacokinetic study
Pescovitz, M. D., Brook, B., Jindal, R. M., Leapman, S. B., Milgrom, M. L., & Filo, R. S. (1997) · Clinical Transplantation · doi:10.1111/j.1399-0012.1997.tb01053.x · Cited by 25
Self-citationProgress in the Clinical Management of Herpesvirus Infections
Griffiths, P. D. (1995) · Antiviral chemistry & chemotherapy · doi:10.1177/095632029500600401 · Cited by 20
Cited by
Kotton, C. N., Kumar, D., Caliendo, A. M., Huprikar, S., Chou, S., Danziger-Isakov, L., & Humar, A. (2018) · Transplantation · doi:10.1097/tp.0000000000002191 · Cited by 1,152
Paya, C., Humar, A., Dominguez, E., Washburn, K., Blumberg, E., Alexander, B., Freeman, R., Heaton, N., & Pescovitz, M. D. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00382.x · Cited by 880
Self-citationBoeckh, M., Nichols, W. G., Papanicolaou, G., Rubin, R., Wingard, J. R., & Zaia, J. (2003) · Biology of Blood and Marrow Transplantation · doi:10.1016/s1083-8791(03)00287-8 · Cited by 431
Asberg, A., Humar, A., Rollag, H., Jardine, A. G., Mouas, H., Pescovitz, M. D., Sgarabotto, D., Tuncer, M., Noronha, I. L., & Hartmann, A. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.01910.x · Cited by 430
Self-citationA Controlled Trial of Valganciclovir as Induction Therapy for Cytomegalovirus Retinitis
Martin, D. F., Sierra-Madero, J., Walmsley, S., Wolitz, R. A., Macey, K., Georgiou, P., Robinson, C. A., & Stempien, M. J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011759 · Cited by 394
Self-citation
Metadata
- Authors
- Pescovitz, M. D., Rabkin, J., Merion, R. M., Paya, C. V., Pirsch, J., Freeman, R. B., O'Grady, J., Robinson, C., To, Z., Wren, K., Banken, L., Buhles, W., & Brown, F.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2000-10
- Volume
- 44
- Issue
- 10
- Pages
- 2811-2815
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2061974719
- Cited by
- 357
- References
- 16
- FWCI
- 10.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.